It’s February 2020 and drugmaker Moderna’s sprinting ahead – its Covid vaccine is already poised to enter human trials.But Moderna and its rivals know plenty of vaccines never make it out of trials alive. It’s also going to take a lot of manufacturing muscle to inoculate the world. All of which costs a lot of moolah.And if the vaccine makers can’t secure a d ... Show More
Oct 2021
La course au vaccin | On part de loin ! | 3
Nous sommes en février 2020, et le laboratoire Moderna vient de prendre la tête de la course au vaccin, avec un candidat-vaccin déjà prêt à être testé sur l’homme.Mais Moderna et les autres laboratoires, savent très bien que beaucoup de vaccins ne passent jamais cette étape fatid ... Show More
27m 47s
Nov 2020
Dispatch 13: Challenge Trials
<p>What if someone asked you to get infected with the COVID-19 virus, deliberately, in order to speed up the development of a vaccine? Would you do it? Would you risk your life to save others?</p>
<p>For months, dozens of companies have been racing to create coronavirus vaccines. ... Show More
26m 36s
Sep 2020
What We Can't Know About a Vaccine
The race for a COVID-19 vaccine entered a new phase recently. Four different vaccine candidates, developed by Moderna, Pfizer, BionTech and Johnson & Johnson, entered final-stage trials, with two others close behind. But we won’t know exactly how these four vaccines work for mont ... Show More
13m 57s